![Theis Terwey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 43 M $ al 31/05/2026
Theis Terwey was the founder of GH Research Plc, founded in 2018, and held the title of Chief Executive Officer from 2021 to 2024.
Former jobs include Managing Director at NB Capital Research GmbH from 2009 to 2015 and Partner at NB Capital ApS from 2015 to 2020.
Education includes a doctorate from Charité - Universitätsmedizin Berlin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GH RESEARCH PLC 2,6 % | 30/09/2025 | 1.784.266 ( 2,6 % ) | 43 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| GH RESEARCH PLC | Fundador | 03/09/2024 |
NB Capital ApS | Corporate Officer/Principal | 01/01/2020 |
NB Capital Research GmbH | Corporate Officer/Principal | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Charité - Universitätsmedizin Berlin
 Charité - Universitätsmedizin Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GH Research Plc
 GH Research Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapies for the management of psychiatric and neurological disorders | Health Technology |
NB Capital Research GmbH | |
NB Capital ApS |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
